Your session is about to expire
What is Gimoti
MetoclopramideThe Generic name of this drug
Treatment SummaryMetoclopramide is a medication used to treat nausea and vomiting caused by diabetic gastroparesis, a condition that affects the stomach's ability to empty. It can also be used to treat gastroesophageal reflux disease (GERD) or prevent nausea or vomiting caused by chemotherapy or certain medical procedures. Metoclopramide is available as an oral tablet or liquid solution and can be given intravenously. It was approved by the FDA in 1980 and works by blocking dopamine receptors in the body, without increasing gastric acid secretion.
Metoclopramideis the brand name
Gimoti Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Metoclopramide
Metoclopramide
1985
199
Approved as Treatment by the FDA
Metoclopramide, commonly known as Metoclopramide, is approved by the FDA for 3 uses including Failed conventional therapy and Gastroesophageal Reflux Disease (GERD) .Failed conventional therapy
Gastroesophageal Reflux Disease (GERD)
Gastroparesis
Effectiveness
How Gimoti Affects PatientsMetoclopramide helps food move through the stomach by loosening the lower esophageal sphincter (LES). It can also reduce nausea and vomiting. Metoclopramide also helps the stomach to move food without increasing bile, stomach acid, or pancreatic secretions. Taking this drug for more than twelve weeks can cause tardive dyskinesia, dystonia, and akathisia, so it should not be taken for long periods of time.
How Gimoti works in the bodyMetoclopramide works to prevent nausea and vomiting by blocking dopamine and serotonin receptors in your brain's chemoreceptor trigger zone. It also helps move food through your digestive system faster by blocking certain receptors and increasing the release of acetylcholine, which helps contract your stomach muscles. Finally, it blocks a type of receptor that dopamine binds to, causing relaxation in your digestive system.
When to interrupt dosage
The prescribed dosage of Gimoti is dependent upon the diagnosed affliction, including Nausea, Intubation (procedure) and Gastroesophageal Reflux Disease (GERD). The measure of dosage changes, depending on the method of delivery (e.g. Spray or Tablet, orally disintegrating) featured in the following table.Condition
Dosage
Administration
Pharmacotherapy
10.0 mg, , 5.0 mg, 5.0 mg/mL, 10.0 mg/mL, 1.0 mg/mL, 1.0 mg, 9.0 mg/mL, 1500.0 mg/mL
, Oral, Tablet - Oral, Tablet, Solution, Solution - Oral, Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Injection, solution, Injection, solution - Intramuscular; Intravenous, Intravenous, Injection - Intravenous, Liquid, Liquid - Intramuscular; Intravenous, Syrup, Syrup - Oral, Liquid - Oral, Liquid - Intravenous, Injection, solution - Intravenous, Oral; Topical, Kit, Kit - Oral; Topical, Spray, Spray - Nasal, Nasal, Solution - Intramuscular; Intravenous
Nausea
10.0 mg, , 5.0 mg, 5.0 mg/mL, 10.0 mg/mL, 1.0 mg/mL, 1.0 mg, 9.0 mg/mL, 1500.0 mg/mL
, Oral, Tablet - Oral, Tablet, Solution, Solution - Oral, Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Injection, solution, Injection, solution - Intramuscular; Intravenous, Intravenous, Injection - Intravenous, Liquid, Liquid - Intramuscular; Intravenous, Syrup, Syrup - Oral, Liquid - Oral, Liquid - Intravenous, Injection, solution - Intravenous, Oral; Topical, Kit, Kit - Oral; Topical, Spray, Spray - Nasal, Nasal, Solution - Intramuscular; Intravenous
prophylaxis of Hiccups
10.0 mg, , 5.0 mg, 5.0 mg/mL, 10.0 mg/mL, 1.0 mg/mL, 1.0 mg, 9.0 mg/mL, 1500.0 mg/mL
, Oral, Tablet - Oral, Tablet, Solution, Solution - Oral, Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Injection, solution, Injection, solution - Intramuscular; Intravenous, Intravenous, Injection - Intravenous, Liquid, Liquid - Intramuscular; Intravenous, Syrup, Syrup - Oral, Liquid - Oral, Liquid - Intravenous, Injection, solution - Intravenous, Oral; Topical, Kit, Kit - Oral; Topical, Spray, Spray - Nasal, Nasal, Solution - Intramuscular; Intravenous
Failed conventional therapy
10.0 mg, , 5.0 mg, 5.0 mg/mL, 10.0 mg/mL, 1.0 mg/mL, 1.0 mg, 9.0 mg/mL, 1500.0 mg/mL
, Oral, Tablet - Oral, Tablet, Solution, Solution - Oral, Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Injection, solution, Injection, solution - Intramuscular; Intravenous, Intravenous, Injection - Intravenous, Liquid, Liquid - Intramuscular; Intravenous, Syrup, Syrup - Oral, Liquid - Oral, Liquid - Intravenous, Injection, solution - Intravenous, Oral; Topical, Kit, Kit - Oral; Topical, Spray, Spray - Nasal, Nasal, Solution - Intramuscular; Intravenous
Hyperacidity
10.0 mg, , 5.0 mg, 5.0 mg/mL, 10.0 mg/mL, 1.0 mg/mL, 1.0 mg, 9.0 mg/mL, 1500.0 mg/mL
, Oral, Tablet - Oral, Tablet, Solution, Solution - Oral, Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Injection, solution, Injection, solution - Intramuscular; Intravenous, Intravenous, Injection - Intravenous, Liquid, Liquid - Intramuscular; Intravenous, Syrup, Syrup - Oral, Liquid - Oral, Liquid - Intravenous, Injection, solution - Intravenous, Oral; Topical, Kit, Kit - Oral; Topical, Spray, Spray - Nasal, Nasal, Solution - Intramuscular; Intravenous
meteorism
10.0 mg, , 5.0 mg, 5.0 mg/mL, 10.0 mg/mL, 1.0 mg/mL, 1.0 mg, 9.0 mg/mL, 1500.0 mg/mL
, Oral, Tablet - Oral, Tablet, Solution, Solution - Oral, Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Injection, solution, Injection, solution - Intramuscular; Intravenous, Intravenous, Injection - Intravenous, Liquid, Liquid - Intramuscular; Intravenous, Syrup, Syrup - Oral, Liquid - Oral, Liquid - Intravenous, Injection, solution - Intravenous, Oral; Topical, Kit, Kit - Oral; Topical, Spray, Spray - Nasal, Nasal, Solution - Intramuscular; Intravenous
Acute Coryza
10.0 mg, , 5.0 mg, 5.0 mg/mL, 10.0 mg/mL, 1.0 mg/mL, 1.0 mg, 9.0 mg/mL, 1500.0 mg/mL
, Oral, Tablet - Oral, Tablet, Solution, Solution - Oral, Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Injection, solution, Injection, solution - Intramuscular; Intravenous, Intravenous, Injection - Intravenous, Liquid, Liquid - Intramuscular; Intravenous, Syrup, Syrup - Oral, Liquid - Oral, Liquid - Intravenous, Injection, solution - Intravenous, Oral; Topical, Kit, Kit - Oral; Topical, Spray, Spray - Nasal, Nasal, Solution - Intramuscular; Intravenous
Pharmacotherapy
10.0 mg, , 5.0 mg, 5.0 mg/mL, 10.0 mg/mL, 1.0 mg/mL, 1.0 mg, 9.0 mg/mL, 1500.0 mg/mL
, Oral, Tablet - Oral, Tablet, Solution, Solution - Oral, Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Injection, solution, Injection, solution - Intramuscular; Intravenous, Intravenous, Injection - Intravenous, Liquid, Liquid - Intramuscular; Intravenous, Syrup, Syrup - Oral, Liquid - Oral, Liquid - Intravenous, Injection, solution - Intravenous, Oral; Topical, Kit, Kit - Oral; Topical, Spray, Spray - Nasal, Nasal, Solution - Intramuscular; Intravenous
Gastroparesis
10.0 mg, , 5.0 mg, 5.0 mg/mL, 10.0 mg/mL, 1.0 mg/mL, 1.0 mg, 9.0 mg/mL, 1500.0 mg/mL
, Oral, Tablet - Oral, Tablet, Solution, Solution - Oral, Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Injection, solution, Injection, solution - Intramuscular; Intravenous, Intravenous, Injection - Intravenous, Liquid, Liquid - Intramuscular; Intravenous, Syrup, Syrup - Oral, Liquid - Oral, Liquid - Intravenous, Injection, solution - Intravenous, Oral; Topical, Kit, Kit - Oral; Topical, Spray, Spray - Nasal, Nasal, Solution - Intramuscular; Intravenous
Nausea
10.0 mg, , 5.0 mg, 5.0 mg/mL, 10.0 mg/mL, 1.0 mg/mL, 1.0 mg, 9.0 mg/mL, 1500.0 mg/mL
, Oral, Tablet - Oral, Tablet, Solution, Solution - Oral, Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Injection, solution, Injection, solution - Intramuscular; Intravenous, Intravenous, Injection - Intravenous, Liquid, Liquid - Intramuscular; Intravenous, Syrup, Syrup - Oral, Liquid - Oral, Liquid - Intravenous, Injection, solution - Intravenous, Oral; Topical, Kit, Kit - Oral; Topical, Spray, Spray - Nasal, Nasal, Solution - Intramuscular; Intravenous
Aerophagy
10.0 mg, , 5.0 mg, 5.0 mg/mL, 10.0 mg/mL, 1.0 mg/mL, 1.0 mg, 9.0 mg/mL, 1500.0 mg/mL
, Oral, Tablet - Oral, Tablet, Solution, Solution - Oral, Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Injection, solution, Injection, solution - Intramuscular; Intravenous, Intravenous, Injection - Intravenous, Liquid, Liquid - Intramuscular; Intravenous, Syrup, Syrup - Oral, Liquid - Oral, Liquid - Intravenous, Injection, solution - Intravenous, Oral; Topical, Kit, Kit - Oral; Topical, Spray, Spray - Nasal, Nasal, Solution - Intramuscular; Intravenous
Indigestion
10.0 mg, , 5.0 mg, 5.0 mg/mL, 10.0 mg/mL, 1.0 mg/mL, 1.0 mg, 9.0 mg/mL, 1500.0 mg/mL
, Oral, Tablet - Oral, Tablet, Solution, Solution - Oral, Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Injection, solution, Injection, solution - Intramuscular; Intravenous, Intravenous, Injection - Intravenous, Liquid, Liquid - Intramuscular; Intravenous, Syrup, Syrup - Oral, Liquid - Oral, Liquid - Intravenous, Injection, solution - Intravenous, Oral; Topical, Kit, Kit - Oral; Topical, Spray, Spray - Nasal, Nasal, Solution - Intramuscular; Intravenous
Gastric Acid
10.0 mg, , 5.0 mg, 5.0 mg/mL, 10.0 mg/mL, 1.0 mg/mL, 1.0 mg, 9.0 mg/mL, 1500.0 mg/mL
, Oral, Tablet - Oral, Tablet, Solution, Solution - Oral, Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Injection, solution, Injection, solution - Intramuscular; Intravenous, Intravenous, Injection - Intravenous, Liquid, Liquid - Intramuscular; Intravenous, Syrup, Syrup - Oral, Liquid - Oral, Liquid - Intravenous, Injection, solution - Intravenous, Oral; Topical, Kit, Kit - Oral; Topical, Spray, Spray - Nasal, Nasal, Solution - Intramuscular; Intravenous
Intubation (procedure)
10.0 mg, , 5.0 mg, 5.0 mg/mL, 10.0 mg/mL, 1.0 mg/mL, 1.0 mg, 9.0 mg/mL, 1500.0 mg/mL
, Oral, Tablet - Oral, Tablet, Solution, Solution - Oral, Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Injection, solution, Injection, solution - Intramuscular; Intravenous, Intravenous, Injection - Intravenous, Liquid, Liquid - Intramuscular; Intravenous, Syrup, Syrup - Oral, Liquid - Oral, Liquid - Intravenous, Injection, solution - Intravenous, Oral; Topical, Kit, Kit - Oral; Topical, Spray, Spray - Nasal, Nasal, Solution - Intramuscular; Intravenous
gastric emptying for radiologic procedures
10.0 mg, , 5.0 mg, 5.0 mg/mL, 10.0 mg/mL, 1.0 mg/mL, 1.0 mg, 9.0 mg/mL, 1500.0 mg/mL
, Oral, Tablet - Oral, Tablet, Solution, Solution - Oral, Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Injection, solution, Injection, solution - Intramuscular; Intravenous, Intravenous, Injection - Intravenous, Liquid, Liquid - Intramuscular; Intravenous, Syrup, Syrup - Oral, Liquid - Oral, Liquid - Intravenous, Injection, solution - Intravenous, Oral; Topical, Kit, Kit - Oral; Topical, Spray, Spray - Nasal, Nasal, Solution - Intramuscular; Intravenous
Therapeutic procedure
10.0 mg, , 5.0 mg, 5.0 mg/mL, 10.0 mg/mL, 1.0 mg/mL, 1.0 mg, 9.0 mg/mL, 1500.0 mg/mL
, Oral, Tablet - Oral, Tablet, Solution, Solution - Oral, Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Injection, solution, Injection, solution - Intramuscular; Intravenous, Intravenous, Injection - Intravenous, Liquid, Liquid - Intramuscular; Intravenous, Syrup, Syrup - Oral, Liquid - Oral, Liquid - Intravenous, Injection, solution - Intravenous, Oral; Topical, Kit, Kit - Oral; Topical, Spray, Spray - Nasal, Nasal, Solution - Intramuscular; Intravenous
Nausea
10.0 mg, , 5.0 mg, 5.0 mg/mL, 10.0 mg/mL, 1.0 mg/mL, 1.0 mg, 9.0 mg/mL, 1500.0 mg/mL
, Oral, Tablet - Oral, Tablet, Solution, Solution - Oral, Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Injection, solution, Injection, solution - Intramuscular; Intravenous, Intravenous, Injection - Intravenous, Liquid, Liquid - Intramuscular; Intravenous, Syrup, Syrup - Oral, Liquid - Oral, Liquid - Intravenous, Injection, solution - Intravenous, Oral; Topical, Kit, Kit - Oral; Topical, Spray, Spray - Nasal, Nasal, Solution - Intramuscular; Intravenous
Gastroparesis
10.0 mg, , 5.0 mg, 5.0 mg/mL, 10.0 mg/mL, 1.0 mg/mL, 1.0 mg, 9.0 mg/mL, 1500.0 mg/mL
, Oral, Tablet - Oral, Tablet, Solution, Solution - Oral, Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Injection, solution, Injection, solution - Intramuscular; Intravenous, Intravenous, Injection - Intravenous, Liquid, Liquid - Intramuscular; Intravenous, Syrup, Syrup - Oral, Liquid - Oral, Liquid - Intravenous, Injection, solution - Intravenous, Oral; Topical, Kit, Kit - Oral; Topical, Spray, Spray - Nasal, Nasal, Solution - Intramuscular; Intravenous
Gastrointestinal distress
10.0 mg, , 5.0 mg, 5.0 mg/mL, 10.0 mg/mL, 1.0 mg/mL, 1.0 mg, 9.0 mg/mL, 1500.0 mg/mL
, Oral, Tablet - Oral, Tablet, Solution, Solution - Oral, Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Injection, solution, Injection, solution - Intramuscular; Intravenous, Intravenous, Injection - Intravenous, Liquid, Liquid - Intramuscular; Intravenous, Syrup, Syrup - Oral, Liquid - Oral, Liquid - Intravenous, Injection, solution - Intravenous, Oral; Topical, Kit, Kit - Oral; Topical, Spray, Spray - Nasal, Nasal, Solution - Intramuscular; Intravenous
Flatulence
10.0 mg, , 5.0 mg, 5.0 mg/mL, 10.0 mg/mL, 1.0 mg/mL, 1.0 mg, 9.0 mg/mL, 1500.0 mg/mL
, Oral, Tablet - Oral, Tablet, Solution, Solution - Oral, Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Injection, solution, Injection, solution - Intramuscular; Intravenous, Intravenous, Injection - Intravenous, Liquid, Liquid - Intramuscular; Intravenous, Syrup, Syrup - Oral, Liquid - Oral, Liquid - Intravenous, Injection, solution - Intravenous, Oral; Topical, Kit, Kit - Oral; Topical, Spray, Spray - Nasal, Nasal, Solution - Intramuscular; Intravenous
Warnings
Gimoti ContraindicationsCondition
Risk Level
Notes
Severe Hypersensitivity Reactions
Do Not Combine
Metoclopramide may interact with Pulse Frequency
Mechanical Intestinal Obstruction
Do Not Combine
Gastrointestinal Hemorrhage
Do Not Combine
Gastrointestinal Perforation
Do Not Combine
catecholamine-releasing paragangliomas
Do Not Combine
Tardive Dyskinesia
Do Not Combine
Pharmaceutical Preparations
Do Not Combine
Pheochromocytomas
Do Not Combine
Parkinson's Disease
Do Not Combine
Depression
Do Not Combine
Epilepsies
Do Not Combine
Gastrectomy
Do Not Combine
Dystonia
Do Not Combine
Feeling suicidal (finding)
Do Not Combine
Common Gimoti Drug Interactions
Drug Name
Risk Level
Description
Acepromazine
Major
The risk or severity of adverse effects can be increased when Metoclopramide is combined with Acepromazine.
Aceprometazine
Major
The risk or severity of adverse effects can be increased when Metoclopramide is combined with Aceprometazine.
Acetophenazine
Major
The risk or severity of adverse effects can be increased when Metoclopramide is combined with Acetophenazine.
Alimemazine
Major
The risk or severity of adverse effects can be increased when Metoclopramide is combined with Alimemazine.
Amisulpride
Major
The risk or severity of adverse effects can be increased when Metoclopramide is combined with Amisulpride.
Gimoti Toxicity & Overdose RiskThe maximum toxic dose of metoclopramide in rats has been found to be 750mg/kg. Symptoms of an overdose include drowsiness, confusion, and muscular disorders. Medications typically used to treat Parkinson's disease or anticholinergic drugs may alleviate these muscular symptoms, which usually disappear within 24 hours. Infants who overdose on the oral solution of metoclopramide often experience seizures, muscular disorders, and lethargy. Methemoglobinemia has been reported in premature and full-term babies after a metoclopramide overdose and can be treated with intravenous methylene blue, though this
Gimoti Novel Uses: Which Conditions Have a Clinical Trial Featuring Gimoti?
113 active clinical trials are currently investigating the potential of Gimoti as a treatment for Migraine, Nausea and Pharmacotherapeutic applications.Condition
Clinical Trials
Trial Phases
Gastric Motility Disorder
0 Actively Recruiting
Migraine
52 Actively Recruiting
Not Applicable, Phase 1, Phase 2, Phase 3, Phase 4, Early Phase 1
Nausea
2 Actively Recruiting
Not Applicable, Phase 4
Acute Coryza
0 Actively Recruiting
Pharmacotherapy
0 Actively Recruiting
Nausea
0 Actively Recruiting
Gastric Acid
0 Actively Recruiting
Gastroparesis
4 Actively Recruiting
Not Applicable, Phase 2
Aerophagy
0 Actively Recruiting
Nausea
0 Actively Recruiting
Flatulence
0 Actively Recruiting
Intubation (procedure)
0 Actively Recruiting
Hiccups
0 Actively Recruiting
Pharmacotherapy
1 Actively Recruiting
Phase 4
Gastroparesis
21 Actively Recruiting
Phase 3, Not Applicable, Early Phase 1, Phase 2
Gastroesophageal Reflux Disease (GERD)
25 Actively Recruiting
Not Applicable, Phase 3, Phase 1, Phase 2, Phase 4
Nausea
0 Actively Recruiting
Failed conventional therapy
0 Actively Recruiting
Gastrointestinal distress
21 Actively Recruiting
Not Applicable, Phase 2, Phase 4, Phase 1, Phase 3, Early Phase 1
Therapeutic procedure
0 Actively Recruiting
Gimoti Reviews: What are patients saying about Gimoti?
5Patient Review
4/7/2021 I was really impressed with how quick this worked and how easy it was to use.
5Patient Review
4/20/2021 This product has made a huge difference for me. It's much easier to use than pills, and just as effective.
5Patient Review
4/29/2021 This was a great treatment for me and I would highly recommend it to others!
5Patient Review
4/16/2021 I've tried a lot of different things over the years to help with my gastroparesis, but this is by far the best I've found. Gimoti has made a total step change in my condition and I feel like I'm finally winning the battle against this terrible disease.
5Patient Review
4/16/2021 This was a huge help in reducing my nausea. It's also much more consistent than the pill form of Reglan, which I've used in the past. The nose spray is easy to use and works quickly, which is great.
5Patient Review
4/19/2021 So easy to use and very convenient. I just started using it and already see a difference.
5Patient Review
4/18/2021 I've been on this medication for about a month and it's going really well!
5Patient Review
4/13/2021 So far, I've been taking this medication three times a day for two months and I haven't experienced any negative side effects. Hopefully I'll be able to keep using it long-term!
5Patient Review
4/12/2021 I'm really impressed with this medication. So far, I haven't experienced any negative side effects.
5Patient Review
4/8/2021 When I was too sick to function, this medication really helped me out. Not only that, but it alleviated my nausea quickly.
5Patient Review
4/12/2021 So far, I'm having much better results with this treatment than with oral metoclopramide.
5Patient Review
4/30/2021 Symptom control has been much more consistent for me since starting this treatment three weeks ago.
5Patient Review
4/13/2021 I had a great experience with this product! I usually have difficulty using Reglan, but this one was much better.
4.3Patient Review
4/14/2021 I found the spray to be more effective than taking the pill form of this medication.
Patient Q&A Section about gimoti
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.Does metoclopramide make you drowsy?
"Some potential side effects of metoclopramide are drowsiness and excessive tiredness. If you experience either of these symptoms, be sure to let your doctor know."
Answered by AI
What is Gimoti used for?
"A person with diabetes may experience a complication where their stomach digestion has slowed down. This condition is called diabetic gastroparesis. Gimoti (metoclopramide) is a nasal spray that can help treat this condition. Currently, it is only available as a brand-name product and is usually more expensive than alternative medications."
Answered by AI
How does metoclopramide work?
"Metoclopramide works by blocking the communication between the CTZ and the vomiting center. This helps to reduce nausea and prevent vomiting. Metoclopramide tablets and liquid typically start working within 30 to 60 minutes."
Answered by AI
Is Gimoti available?
"You can only get GIMOTI through vitaCare Prescription Services. They will give you a call after you have sent in your prescription to set up a delivery."
Answered by AI